Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialysis

Chiao Ying Sun, Hou Chang Lin, Yung Chih Chen, Chi Ren Tsai, Mai Szu Wu

Research output: Contribution to journalArticle

4 Citations (Scopus)


Methotrexate has been used as an important alternative therapy in the treatment of various rheumatic diseases. Life threatening marrow suppression in end-stage renal disease patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis has been reported. A 33-year-old woman with systemic lupus erythematosus undergoing chronic peritoneal dialysis developed severe mucositis and pancytopenia after low-dose methotrexate treatment for arthritis. The leukocyte count recovered after methotrexate was withdrawn but a leukemoid blood picture developed during her recovery. No evidence of leukemia was found on bone marrow biopsy. The leukocyte count gradually returned to normal with conservative therapy.

Original languageEnglish
Pages (from-to)513-517
Number of pages5
JournalChang Gung Medical Journal
Issue number5
Publication statusPublished - Sep 2006
Externally publishedYes



  • Continuous ambulatory peritoneal dialysis
  • Leukemoid reaction
  • Methotrexate
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Medicine(all)

Cite this